Published in Pediatrics on January 01, 2009
Bariatric surgery for obese children and adolescents: a review of the moral challenges. BMC Med Ethics (2013) 0.81
Overweight and obesity among maltreated young adolescents. Child Abuse Negl (2012) 0.79
Childhood Obesity and the Right to Health. Health Hum Rights (2016) 0.75
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Prevalence of overweight and obesity in the United States, 1999-2004. JAMA (2006) 72.59
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med (2001) 56.11
Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA (2002) 23.79
The disease burden associated with overweight and obesity. JAMA (1999) 19.39
Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med (1997) 19.30
Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med (2007) 18.45
Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med (1999) 16.57
Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med (2006) 16.17
Long-term mortality after gastric bypass surgery. N Engl J Med (2007) 10.75
Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics (1998) 10.51
Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Pediatr (2007) 9.60
Health consequences of obesity. Arch Dis Child (2003) 7.71
Screening and interventions for childhood overweight: a summary of evidence for the US Preventive Services Task Force. Pediatrics (2005) 5.22
Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics (2004) 5.01
Clinical practice. Overweight children and adolescents. N Engl J Med (2005) 3.85
Treatment of pediatric obesity. Pediatrics (1998) 3.02
Interventions for treating obesity in children. Cochrane Database Syst Rev (2003) 3.00
Case records of the Massachusetts General Hospital. Case 31-2006. A 15-year-old girl with severe obesity. N Engl J Med (2006) 2.71
Childhood obesity. J Clin Endocrinol Metab (2004) 2.29
Bariatric surgery in adolescents: recent national trends in use and in-hospital outcome. Arch Pediatr Adolesc Med (2007) 1.66
Surgery for morbid obesity. Cochrane Database Syst Rev (2005) 1.45
The relation of obesity throughout life to carotid intima-media thickness in adulthood: the Bogalusa Heart Study. Int J Obes Relat Metab Disord (2004) 1.41
Obesity in youth is not an independent predictor of carotid IMT in adulthood. The Cardiovascular Risk in Young Finns Study. Atherosclerosis (2005) 1.25
Extreme pediatric obesity: weighing the health dangers. J Pediatr (2007) 1.17
Bariatric surgery for pediatric extreme obesity: now or later? Int J Obes (Lond) (2007) 1.17
Pharmacotherapy of childhood obesity: an evidence-based, conceptual approach. Diabetes Care (2007) 1.01
A critical appraisal of evidence supporting a bariatric surgical approach to weight management for adolescents. J Pediatr (2005) 0.98
Adolescent substance abuse. Confidentiality and consent. Pediatr Clin North Am (2002) 0.80
BMA rejects call for parents of obese children to be charged with neglect. BMJ (2007) 0.77
The overweight adolescent: clinical and ethical issues in intensive treatments for pediatric obesity. J Pediatr (2005) 0.77
Ashley revisited: a response to the critics. Am J Bioeth (2010) 7.15
Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med (2006) 6.10
The dysregulation of human subjects research. JAMA (2007) 3.44
Improvement of fitness, body composition, and insulin sensitivity in overweight children in a school-based exercise program: a randomized, controlled study. Arch Pediatr Adolesc Med (2005) 2.96
Community consultation and communication for a population-based DNA biobank: the Marshfield clinic personalized medicine research project. Am J Med Genet A (2008) 2.74
The cystic fibrosis gene: medical and social implications for heterozygote detection. JAMA (1990) 2.02
Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome. J Pediatr (2004) 1.91
GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab (2013) 1.74
Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development. Clin Endocrinol (Oxf) (2008) 1.67
Health Insurance Portability Accountability Act (HIPAA) regulations: effect on medical record research. Ann Surg (2004) 1.55
Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls. J Pediatr (2005) 1.54
School-based fitness changes are lost during the summer vacation. Arch Pediatr Adolesc Med (2007) 1.51
Sex-related differences in immune development and the expression of atopy in early childhood. J Allergy Clin Immunol (2006) 1.39
Environment and obesity in the National Children's Study. Environ Health Perspect (2008) 1.34
Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. J Clin Endocrinol Metab (2002) 1.22
An Institutional Review Board dilemma: responsible for safety monitoring but not in control. Clin Trials (2006) 1.11
Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome. J Clin Endocrinol Metab (2010) 1.11
Fitness is a stronger predictor of fasting insulin levels than fatness in overweight male middle-school children. J Pediatr (2007) 1.10
Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. Am J Med Genet A (2007) 1.10
Home food availability, parental dietary intake, and familial eating habits influence the diet quality of urban Hispanic children. Child Obes (2014) 1.08
Genetic data and electronic health records: a discussion of ethical, logistical and technological considerations. J Am Med Inform Assoc (2013) 1.03
hGH for short stature: ethical issues raised by expanded access. J Pediatr (2004) 1.00
Evaluation of tests of hypothalamic-pituitary-adrenal axis function used to measure effects of inhaled corticosteroids. Ann Allergy Asthma Immunol (2007) 1.00
Standardized childhood fitness percentiles derived from school-based testing. J Pediatr (2012) 0.98
Characteristics of adolescents presenting to a multidisciplinary clinic for polycystic ovarian syndrome. J Pediatr Adolesc Gynecol (2009) 0.96
Growth of preschool children at high risk for asthma 2 years after discontinuation of fluticasone. J Allergy Clin Immunol (2011) 0.90
Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome. J Pediatr (2003) 0.90
Ethical issues in clinical research on fracture prevention in patients with osteoporosis. J Bone Miner Res (2003) 0.90
Clinical outcomes and adverse effect monitoring in allergic rhinitis. J Allergy Clin Immunol (2005) 0.88
School-based exercise improves fitness, body composition, insulin sensitivity, and markers of inflammation in non-obese children. J Pediatr Endocrinol Metab (2009) 0.88
Proton density fat-fraction is an accurate biomarker of hepatic steatosis in adolescent girls and young women. Eur Radiol (2015) 0.88
Deferring consent with incompetent patients in an intensive care unit. IRB (1981) 0.87
Effect of conjugated linoleic acid on body fat accretion in overweight or obese children. Am J Clin Nutr (2010) 0.87
Submaximal treadmill test predicts VO2max in overweight children. J Pediatr (2009) 0.86
Reliable prediction of insulin resistance by a school-based fitness test in middle-school children. Int J Pediatr Endocrinol (2009) 0.84
TODAY--a stark glimpse of tomorrow. N Engl J Med (2012) 0.84
Off the growth curve: the challenge of childhood obesity. WMJ (2005) 0.84
A pilot seminar on ethical issues in clinical trials for cancer researchers in Vietnam. IRB (2004) 0.83
Ethnic differences in the effects of hepatic fat deposition on insulin resistance in nonobese middle school girls. Obesity (Silver Spring) (2013) 0.82
Fitness level and body composition are associated with inflammation in non-obese children. J Pediatr Endocrinol Metab (2009) 0.81
Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions. J Pediatr (2005) 0.81
Growth hormone therapy for Prader-Willi syndrome: a critical appraisal. J Pediatr Endocrinol Metab (2004) 0.81
Inhaled corticosteroids, growth, and compliance. N Engl J Med (2002) 0.80
Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention. J Interv Cardiol (2003) 0.80
Growth hormone post-marketing surveillance: safety, sales, and the unfinished task ahead. J Clin Endocrinol Metab (2010) 0.79
Passive euthanasia of defective newborn infants: legal considerations. J Pediatr Surg (1976) 0.79
Prenatal screening for cystic fibrosis: where are we now? J Pediatr (2002) 0.79
Growth-attenuation therapy: principles for practice. Pediatrics (2009) 0.78
Oxandrolone Improves Height Velocity and BMI in Patients with Cystic Fibrosis. Int J Pediatr Endocrinol (2010) 0.78
Long-term effects of recombinant human growth hormone therapy in children with Prader-Willi syndrome. Curr Opin Pediatr (2013) 0.78
Gender and race influence metabolic benefits of fitness in children: a cross-sectional study. Int J Pediatr Endocrinol (2012) 0.78
DXA provides a valid minimum weight in wrestlers. Med Sci Sports Exerc (2007) 0.78
Twenty years of recombinant human growth hormone in children: relevance to pediatric care providers. Clin Pediatr (Phila) (2007) 0.78
Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency. Horm Res Paediatr (2016) 0.77
Perceived risks of participation in an epidemiologic study. IRB (1993) 0.77
Pituitary Antibodies in an Adolescent with Secondary Adrenal Insufficiency and Turner Syndrome. Horm Res Paediatr (2016) 0.77
In Nonobese Girls, Waist Circumference as a Predictor of Insulin Resistance Is Comparable to MRI Fat Measures and Superior to BMI. Horm Res Paediatr (2015) 0.77
The ambiguities of 'deferred consent' IRB (1981) 0.76
Weight perceptions of parents with children at risk for diabetes. BMC Res Notes (2012) 0.76
"Doping" is pejorative and misleading. BMJ (2008) 0.75
Additional sensitivity data for newborn screening for congenital adrenal hyperplasia in Wisconsin. J Pediatr (2006) 0.75
Hemoglobin-based blood substitutes and risk of myocardial infarction and death. JAMA (2008) 0.75
Respiratory Depression in Young Prader Willi Syndrome Patients following Clonidine Provocation for Growth Hormone Secretion Testing. Int J Pediatr Endocrinol (2010) 0.75
Sense and sensitivity: assessing inhaled corticosteroid effects on the hypothalamic-pituitary-adrenal axis. Ann Allergy Asthma Immunol (2002) 0.75
Poor glycemic control predicts occurrence and progression of microalbuminuria in children with type I diabetes. J Pediatr (2008) 0.75
Identifying children at risk for type 2 diabetes in underserved communities. Diabetes Educ (2011) 0.75
Ashley revisited: a response to the peer commentaries. Am J Bioeth (2010) 0.75
Treating short stature with growth hormone. Virtual Mentor (2005) 0.75
"I was like -- whoa": a commentary on Shapiro's Performance enhancement and the control of attributes. South Calif Law Rev (1991) 0.75
The influence of fitness on insulin resistance in obese children. Rev Endocr Metab Disord (2009) 0.75
Growth Promotion Ethics and the Challenge to Resist Cosmetic Endocrinology . Horm Res Paediatr (2017) 0.75
Disparities in Fitness and Physical Activity Among Children. WMJ (2017) 0.75
In Nonobese Children, Fitness and BMI are Independent Predictors of Fasting Insulin. Pediatr Exerc Sci (2015) 0.75
Measuring aerobic cycling power as an assessment of childhood fitness. J Strength Cond Res (2007) 0.75
Food for thought: Dresser on anorexia. Wis L Rev (1984) 0.75
Boosting The Late Blooming Male: Use of growth promoting agents in the athlete with constitutional delay of growth and puberty. Sports Health (2011) 0.75
Topical fluticasone propionate lotion does not cause HPA axis suppression. J Pediatr (2006) 0.75
Measuring aerobic cycling power as an assessment of childhood fitness. J Strength Cond Res (2008) 0.75
Treatment of seriously ill and handicapped newborns. Crit Care Clin (1986) 0.75
Obesity and neglect: it's about the child. J Pediatr (2012) 0.75
Growth hormone treatment for growth hormone deficiency and idiopathic short stature: new guidelines shaped by the presence and absence of evidence. Curr Opin Pediatr (2017) 0.75
Drug testing in adolescents. Virtual Mentor (2005) 0.75